Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2020

01-12-2020 | Ovarian Cancer | Case report

Mucinous carcinoma originating in the peritoneum diagnosed by an ascites cell block: a case report

Authors: Sachiko Nagao, Motoki Matsuura, Masato Tamate, Shintaro Sugita, Tsuyoshi Saito

Published in: Journal of Medical Case Reports | Issue 1/2020

Login to get access

Abstract

Background

Peritoneal carcinoma is a rare disease that is diagnosed and treated in a manner similar to ovarian cancer. In most cases, the histological type is serous carcinoma, and chemotherapy is effective. However, there are a few case reports of mucinous peritoneal carcinoma. We inferred the histological type before surgery using an ascites cell block sample, which was useful for determining the treatment plan.

Case presentation

Our patient was a 60-year-old Japanese woman. She presented with a feeling of fullness in the abdomen. A computed tomographic scan showed a large quantity of ascitic fluid and thickening of the greater omentum, as well as thickening of the peritoneum at the pouch of Douglas and diaphragm. Hence, peritoneal carcinoma was suspected. The tumor markers carcinoembryonic antigen, cancer antigen 19-9, and cancer antigen 125 were all increased, and no malignant findings were observed in the uterus or ovaries. Cells suggestive of carcinoma were found in the ascitic fluid, and immunostaining by the cell block method suggested the possibility of mucinous carcinoma. The preoperative chemotherapy strategy was changed to short courses, and tumor reduction surgery was planned. Similar to the suspicion before surgery, the pathology results indicated mucinous carcinoma, and the therapeutic effect of chemotherapy was grade 0.

Conclusions

Determining whether peritoneal carcinoma is serous carcinoma is important for therapy and prognostic prediction. In this case, we encountered a patient for whom surgery was chosen because of drug therapy resistance inferred through histological type estimation using the cell block method. Inferring the histological type by cell block preparation is useful for diagnosis and treatment selection.
Literature
1.
go back to reference Lee KR, Tavassoli FA, Prat J, Dietel M. Surface epithelial-stromal tumors. In: Tavassoli FA, Devilee P, editors. Tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 119–20. Lee KR, Tavassoli FA, Prat J, Dietel M. Surface epithelial-stromal tumors. In: Tavassoli FA, Devilee P, editors. Tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 119–20.
2.
go back to reference Gatalica Z, Foster JM, Loggie BW. Low grade peritoneal mucinous carcinomatosis associated with human papilloma virus infection: case report. Croat Med J. 2008;49(5):669–73.CrossRef Gatalica Z, Foster JM, Loggie BW. Low grade peritoneal mucinous carcinomatosis associated with human papilloma virus infection: case report. Croat Med J. 2008;49(5):669–73.CrossRef
3.
go back to reference Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347–51.CrossRef Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347–51.CrossRef
4.
go back to reference Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998;90:841–5.CrossRef Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998;90:841–5.CrossRef
5.
go back to reference Casey MJ, Bewtra C. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer. 2004;3:265–81.CrossRef Casey MJ, Bewtra C. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer. 2004;3:265–81.CrossRef
6.
go back to reference Voultsinos V, Semelka RC, Elias J Jr, Altun E, Huertas C, Woosley JT, et al. Primary peritoneal carcinoma: computed tomography and magnetic resonance findings. J Comput Assist Tomogr. 2008;32:541–7.CrossRef Voultsinos V, Semelka RC, Elias J Jr, Altun E, Huertas C, Woosley JT, et al. Primary peritoneal carcinoma: computed tomography and magnetic resonance findings. J Comput Assist Tomogr. 2008;32:541–7.CrossRef
7.
go back to reference Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, et al. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol. 2012;30:2039–45.CrossRef Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, et al. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol. 2012;30:2039–45.CrossRef
Metadata
Title
Mucinous carcinoma originating in the peritoneum diagnosed by an ascites cell block: a case report
Authors
Sachiko Nagao
Motoki Matsuura
Masato Tamate
Shintaro Sugita
Tsuyoshi Saito
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2020
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-020-02435-4

Other articles of this Issue 1/2020

Journal of Medical Case Reports 1/2020 Go to the issue